eurorehabilitation Of The Hand Post Stroke Using The Myhandtm System In A Sub-Acute Population

IRegained Inc0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Unilateral upper limb impairment caused by a single stroke at least 2 weeks to 6 months prior to the start of the study.
•2. Healthy (or corrected-to-normal) vision and hearing abilities to understand the information communicated by the research investigators.
•3. Ambulatory, and/or able to travel to research study location.
•4. CMSA: Level 3 or greater for hand function, and Shoulder pain
•5. MMSE score Ã¢â?°Â¥ 24
•6. Capacity to consent is established

•1. Diagnosis of a neurological disorder other than stroke that can impede in hand function therapy (e.g. peripheral neuropathy, myopathies, ParkinsonÃ¢â?¬•s disease etc.)
•2. Participants suffering from osteoarthritis or other musculoskeletal or neuromuscular disorders that affect hand function.
•3. Participants with severe systemic disease that has an impact on hand function
•4. Participants with severe spasticity or contractures, that has a limiting impact on hand function therapy.

发起方